Nalfurafine hydrochloride to treat pruritus: a review
Shigeki InuiDepartment of Regenerative Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanAbstract: Uremic pruritus has a great negative influence on quality of life in hemodialysis (HD) patients and, importantly, negatively affects mortality risk. Recently, nalfurafine hydrochlo...
Main Author: | Inui S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-05-01
|
Series: | Clinical, Cosmetic and Investigational Dermatology |
Online Access: | http://www.dovepress.com/nalfurafine-hydrochloride-to-treat-pruritus-a-review-peer-reviewed-article-CCID |
Similar Items
-
Pruritus is common in patients with chronic liver disease and is improved by nalfurafine hydrochloride
by: Shuhei Yoshikawa, et al.
Published: (2021-02-01) -
Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses.
by: Kenya Kamimura, et al.
Published: (2017-01-01) -
Nalfurafine hydrochloride for refractory pruritus in peritoneal dialysis patients: a phase III, multi-institutional, non-controlled, open-label trial
by: Hidetomo Nakamoto, et al.
Published: (2017-12-01) -
Post-marketing surveillance study of the safety and efficacy of nalfurafine hydrochloride (Remitch® capsules 2.5 μg) in 3,762 hemodialysis patients with intractable pruritus
by: Kozono H, et al.
Published: (2018-01-01) -
Nalfurafine hydrochloride, a selective κ opioid receptor agonist, has no reinforcing effect on intravenous self-administration in rhesus monkeys
by: Xiulu Ruan
Published: (2016-09-01)